The hottest Weight Loss Substack posts right now

And their main takeaways
Category
Top Health & Wellness Topics
QTR’s Fringe Finance • 42 implied HN points • 24 Mar 26
  1. Some GLP-1 weight-loss drugs like Ozempic, Wegovy, and Rybelsus have been linked to a rare but serious eye condition (NAION) that can cause sudden vision loss.
  2. The risk for any one person is small (roughly 1 in 10,000), but with millions using these drugs the total number of affected people could be substantial, and higher doses or faster weight loss may raise the risk.
  3. New drugs often arrive with a lot of hype but can reveal serious side effects over time, so patients and doctors should weigh benefits against rare harms and make informed choices.
Experimental Fat Loss • 169 implied HN points • 16 Mar 26
  1. The nosauce + apple cider vinegar protocol produced steady, mostly linear fat loss and reached a new all-time low, with an initial rapid drop in water weight followed by consistent fat loss.
  2. Because the regimen reduces heavy cream, daily protein can fall below about 40 g and trigger protein‑leverage hunger; a single day of increased meat intake resolved the hunger without derailing progress.
  3. A planned tweak is to run two 14‑day bouts separated by a one‑day refeed to capture faster early losses and better manage occasional protein hunger.
Experimental Fat Loss • 212 implied HN points • 08 Mar 26
  1. A very high-fat, protein‑restricted ketogenic pattern (think heavy cream plus limited ruminant meat) produced large, mostly effortless weight loss, better sleep, and no constant hunger, while a typical high‑protein, high‑PUFA “standard keto” failed to keep weight off.
  2. Cutting linoleic acid (seed oils and other high‑PUFA foods) was a major lever — removing those oils and favoring ruminant fats seemed more important than ketosis itself for improving sleep and body composition.
  3. Find what works for you by experimenting: run ~30‑day trials of fat‑, starch‑, and sugar‑based staples, then tweak protein; individual genetics matter, so personalize and iterate based on weight, sleep, and how you feel.
Noahpinion • 30000 implied HN points • 07 Jun 25
  1. Losing weight can be more about paying attention to what you eat rather than just having strong willpower. Being mindful of how much you eat and when you stop can make it easier to lose weight.
  2. Technological solutions, like certain weight-loss drugs, may be better at addressing obesity than social solutions. These medications can help suppress appetite and lead to effective and sustainable weight loss.
  3. Weight loss doesn't have to be a moral or self-worth issue. It's just a matter of managing hunger and attention, and using tools to simplify the process can free up time for more important things.
Experimental Fat Loss • 198 implied HN points • 22 Feb 26
  1. Linoleic acid from seed oils is hypothesized to drive obesity and is stored in body fat, so tissue levels can take several years to fall after dietary change, which makes short-term studies a poor test.
  2. People on low-PUFA diets often see big early weight loss then long plateaus, and experimenting with different foods or additives (rice, sugar, vinegar, lowering salt/glutamate) sometimes produces new lows.
  3. If the linoleic-depletion model is true, further weight loss should be slow and tied to how fast adipose LA drops, but if the dietary additives are effective you should see steadier month-to-month losses; watching results over the next few months can help tell these apart.
Get a weekly roundup of the best Substack posts, by hacker news affinity:
Harnessing the Power of Nutrients • 3474 implied HN points • 03 Mar 24
  1. A high-protein diet is essential for muscle health and weight loss, as it helps maintain lean mass during weight loss.
  2. The amount of protein needed to preserve lean mass during weight loss is higher than the standard recommendation, with around 1.3 grams per kilogram being favored.
  3. High levels of protein in the diet can stress the body's requirements for certain vitamins and minerals, leading to various health issues like poor sleep, anxiety, and skin problems.
Common Sense with Bari Weiss • 370 implied HN points • 16 Jan 26
  1. Drugs like GLP-1s and other quick fixes can improve health or mood for some people, but the evidence is mixed and some users experience worse mental-health symptoms.
  2. Cosmetic procedures often raise self-esteem in the short term, yet those benefits can fade and may harm people with body‑dysmorphic tendencies.
  3. Changing your appearance won’t automatically create self‑love — real and lasting well‑being usually requires inner work and ongoing effort.
Experimental Fat Loss • 134 implied HN points • 12 Feb 26
  1. The nosauce plus ACV approach yields reliable weight loss after an initial rapid water drop and is inexpensive and sustainable when followed.
  2. The diet is fragile: even modest cheats like extra beef, extra vegetables, sour cream, high-sodium drinks, or bread commonly produced stalls and increased hunger.
  3. Refeed behavior shows starches (sourdough, rice and beans) satisfy cravings reasonably well, while large high‑protein meals tended to trigger insatiable hunger and overeating.
Weight and Healthcare • 878 implied HN points • 04 May 24
  1. Behavior-based weight loss interventions usually fail to produce significant, long-term weight loss for most people.
  2. The idea of 'jump starting' weight loss with extreme food/caloric restrictions is generally ill-advised as it can trigger famine responses in the body, making it a weight-gaining machine.
  3. Promoting or selling products like liquid diets by medical professionals is not legally prohibited, but the evidence does not support the effectiveness of 'kick starting' weight loss as a long-term solution.
The Vajenda • 3223 implied HN points • 03 Oct 23
  1. Statins are effective for women in reducing cardiovascular disease risk.
  2. Statin side effects are not as common as believed; most often, it's due to the 'nocebo effect'.
  3. Regular ovarian cancer screening methods like ultrasounds and CA-125 tests are not very effective; focus should be on preventive strategies like oral contraception.
Weight and Healthcare • 678 implied HN points • 08 May 24
  1. Extreme food/caloric restrictions for short-term weight loss have no basis in evidence for long-term significant weight loss.
  2. Tips like using aluminum foil, rearranging food in the cupboards, or changing plate sizes have no substantial evidence backing their effectiveness for sustainable weight loss.
  3. Recycled weight loss tropes without scientific evidence can perpetuate harmful weight cycling and health issues, so it's crucial to ask for research on weight loss claims.
Weight and Healthcare • 838 implied HN points • 13 Apr 24
  1. Wegovy is a weight-loss application for the drug Semaglutide (Ozempic), both owned by Novo Nordisk.
  2. The trial to determine Semaglutide's impact on cardiovascular health was designed by Novo Nordisk and authors with significant financial ties to the company.
  3. Results revealed a modest decrease in cardiovascular events with Semaglutide, but twice as many participants stopped taking it due to adverse events compared to the placebo group.
Weight and Healthcare • 798 implied HN points • 06 Apr 24
  1. Be cautious of the concept of 'food noise' promoted by weight loss drug makers as a rebranding of normal hunger or a way to profit off people's broken relationships with food.
  2. Some weight loss drugs aim to manipulate hunger signals through impacting the brain and gut, with unclear long-term effects and potential risks.
  3. The weight loss industry's push for drugs like GLP-1 agonists raises concerns about informed consent, lack of long-term research, and prioritizing short-term weight loss over potential health consequences.
Weight and Healthcare • 1417 implied HN points • 20 Jan 24
  1. Awaken180 claims to create long-term weight loss, but lacks concrete scientific evidence to support their program.
  2. The program emphasizes weight loss over other aspects of health and success, disregarding the variety of body sizes and individual needs.
  3. Awaken180 relies on caloric and carbohydrate restrictions, potentially involving expensive prepacked food, and might not be sustainable for long-term weight loss.
Weight and Healthcare • 659 implied HN points • 20 Apr 24
  1. The 'Obesity Bill of Rights' is part of a movement lobbying for insurance coverage for weight loss industry products and interventions.
  2. The language used in the 'Obesity Bill of Rights' is rooted in marketing from weight loss companies, not in science.
  3. The rights proposed in the 'Obesity Bill of Rights' seem to prioritize weight loss industry profits over actual healthcare for higher-weight individuals.
Weight and Healthcare • 659 implied HN points • 17 Apr 24
  1. The trial data for Semaglutide (Wegovy) for cardiovascular risk reduction was manipulative and lacking in transparency, raising concerns about conflicts of interest and data sharing.
  2. The study demographics were concerning, with a lack of diversity and representation, particularly skewed towards white men, older participants, and those with existing heart disease.
  3. The actual cardiovascular risk reduction with Semaglutide was much lower than claimed, highlighting issues with study design, data presentation, and potential overemphasis on specific demographics in the results.
Weight and Healthcare • 738 implied HN points • 03 Apr 24
  1. Questionable research can happen due to researchers being influenced by profit interests or an entrenched paradigm.
  2. Some researchers may design studies to support predetermined conclusions, leading to misleading results.
  3. Doctors involved with the weight loss industry may have subconscious biases towards promoting weight loss, despite evidence of its ineffectiveness and harms.
Metabolic Repair • 79 implied HN points • 16 Aug 24
  1. Weight loss can be painful and hard to maintain. Many diets lead to cravings and a drop in energy, making it difficult to stick to them for a long time.
  2. There are painless ways to lose weight by focusing on simple food choices, like the potato diet or high-fat keto. These diets can help you lose weight without feeling deprived or constantly hungry.
  3. Personal habits and lifestyle choices play a big role in weight loss. Customizing your diet to fit your life can make the process smoother and less stressful.
Who is Robert Malone • 35 implied HN points • 15 Feb 26
  1. Avoiding added sugar and eating real, whole foods can lead to weight loss and reduce the risk of pre-diabetes and other chronic diseases.
  2. Simple, consistent habits — not complicated plans — can be sustained long term and help keep 40–50 pounds off for years.
  3. Choosing real food supports farmers and local food systems, so your diet can benefit both your health and the community.
Experimental Fat Loss • 148 implied HN points • 28 Dec 25
  1. A 6‑day mostly water fast (with diet soda and limited energy drinks) was used more as a metabolic diagnostic than a reliable weight‑loss strategy, and it only extended fasting tolerance by one day versus a prior attempt.
  2. Thermogenesis fell dramatically during the fast, causing extreme cold sensitivity even indoors and while bundled up, but normal warmth and heat production returned quickly after refeeding.
  3. Weight loss from the fast was modest and rapidly regained, so it didn’t produce sustainable fat loss; the slight improvement in tolerance might be from apple cider vinegar, longer linoleic‑acid reduction, or lower caffeine, but the cause is uncertain.
Weight and Healthcare • 818 implied HN points • 10 Feb 24
  1. The study on Tirzepatide showed that weight loss for participants slowed after 36 weeks, with those switching to placebo experiencing weight regain while those continuing the drug had a slight weight reduction in the following 52 weeks.
  2. Side effects of Tirzepatide included gastrointestinal issues like nausea, diarrhea, constipation, and vomiting. Close to 82% of participants reported experiencing at least one adverse event during the treatment period.
  3. The study's findings indicate that a significant percentage of participants taking Tirzepatide did not meet the weight reduction thresholds, with a lack of diverse representation among participants and a lack of a weight-neutral comparator group presenting issues in the study design.
Experimental Fat Loss • 99 implied HN points • 07 Jan 26
  1. Fresh artisanal bread with butter is extremely easy to overeat because satiety comes slowly and fades after 4–6 hours, which led to an 8 lb gain in 11 days.
  2. Traditional, non-industrial bread did not trigger the acid reflux problems linked to earlier wheat intolerance, suggesting industrial processing or additives may be the real culprit.
  3. A bread+butter “swamp” lands in the high-carb/high-fat zone that causes bloating and gas and is worse for fat loss than a high-fat heavy-cream approach, though it produced milder hyperphagia than protein-heavy refeeds.
Weight and Healthcare • 898 implied HN points • 24 Jan 24
  1. Weight-related health conditions are health issues that are often labeled as related to weight just because higher-weight individuals have them more frequently.
  2. The labeling of health conditions as 'weight-related' overlooks other factors like weight stigma, weight cycling, and healthcare disparities that could actually be the main contributors.
  3. The concept of 'weight-related conditions' is used to push for risky weight loss interventions and profits, but it doesn't necessarily support the health of higher-weight individuals.
Weight and Healthcare • 818 implied HN points • 03 Feb 24
  1. Tirzepatide, known as Zepbound for weight loss, was initially a Type 2 diabetes medication by Eli Lilly that got FDA approval for weight loss due to its side effect of weight loss. It works by interfering with normal digestion processes and hunger signals.
  2. There are dosing differences between the diabetes and weight loss applications of Tirzepatide. For weight loss, patients are encouraged to continuously increase the dosage to the highest tolerable level, potentially facing side effects that impact their quality of life.
  3. The side effects of Tirzepatide/Zepbound can range from mild discomfort to serious conditions like thyroid C-Cell tumors, gastrointestinal diseases, and pancreatic issues. Patients need to be aware of potential risks, like drug interactions and impact on pregnancy.
Weight and Healthcare • 758 implied HN points • 31 Jan 24
  1. FDA approval of a drug does not mean it is completely without risks; it means the benefits are deemed worth the risks.
  2. The FDA assesses the risks and benefits of a drug based on the research provided by the pharmaceutical company before granting approval.
  3. When it comes to weight loss drugs, the risk/benefit analysis by the FDA may be skewed due to questionable research around weight and health, leading to a lower safety bar for approval.
Weight and Healthcare • 718 implied HN points • 07 Feb 24
  1. The concept of 'ob*esity' as a disease and the idea that it is progressive and relapsing are constructs of the weight loss industry and not scientifically supported.
  2. The study promoting Zepbound/Tirzepatide for weight loss has ties to the pharmaceutical industry, raising questions about potential bias and conflicts of interest among the authors.
  3. The lead author of the study, Louis J. Aronne, has a history of promoting weight loss methods without substantial research backing, raising concerns about the credibility of research surrounding weight loss drugs.
Experimental Fat Loss • 240 implied HN points • 05 Nov 25
  1. The combination of eliminating sauces and taking apple cider vinegar capsules resulted in significant weight loss, about 10 pounds in one month. This approach helped break through previous weight plateaus.
  2. Cutting out sauces led to a reduced appetite and unexpectedly high levels of satiety, making it easier to control food intake.
  3. There were noticeable changes in cravings and food enjoyment, with less desire for previously liked foods and a sense of food anhedonia, where meals became less rewarding.
Weight and Healthcare • 1318 implied HN points • 04 Oct 23
  1. The recommendation for 5-10% weight loss to improve health is widespread but may not have significant impact on individuals' health conditions.
  2. The weight loss recommendation is based on flawed BMI categories, often leading to unrealistic goals for individuals, especially those with obesity.
  3. The focus on weight loss overlooks the importance of evidence-based, individualized medical interventions for all patients, regardless of size.
Weight and Healthcare • 439 implied HN points • 20 Mar 24
  1. Eli Lilly and other pharmaceutical companies are focused on lobbying for insurance coverage of weight loss drugs, pushing for the idea of higher-weight bodies as a 'disease' worth medicating.
  2. The FDA approval for weight loss drugs like Zepbound requires different criteria based on BMI, raising concerns about the risk assessments being tied to body size.
  3. Pharmaceutical companies like Eli Lilly prioritize shareholder interests over customer concerns, raising questions about the true motivations behind their actions.
Experimental Fat Loss • 148 implied HN points • 28 Nov 25
  1. The experiment with a low-sauce diet and apple cider vinegar helped to break a weight plateau, resulting in a loss of over 7 pounds. It's encouraging when you can surpass previous weight goals.
  2. Cheating with extra meat and changing ingredients sometimes interrupted weight loss, but overall the plan seemed to still work effectively. It's a reminder that even small changes can impact results.
  3. The lack of sauce made meals less tasty, leading to cravings. Finding the right balance in diet is key to sustainability, so considering the flavor of food is important.
Weight and Healthcare • 1178 implied HN points • 13 May 23
  1. Jenny Craig, a popular commercial diet program, is shutting down after decades. Despite its promises of weight loss, it failed to show long-term results in studies.
  2. Commercial diet programs like Jenny Craig often rely on a cycle of success and failure, blaming clients for weight regain without acknowledging the limitations of restrictive diets.
  3. The closure of Jenny Craig is a reminder of the lack of evidence behind many weight loss programs, as clients are left without sustainable results.
Weight and Healthcare • 1138 implied HN points • 09 Jul 23
  1. Many weight loss interventions are based on flawed models and fail long-term, leading to weight regain as the body adjusts to food restriction.
  2. The focus on weight loss often overlooks the importance of ensuring that individuals receive adequate nutrition during interventions, potentially putting their health at risk.
  3. Moving towards a weight-neutral paradigm in healthcare can prioritize supporting the health of individuals of all sizes instead of promoting unhealthy weight loss methods and stigma.
Weight and Healthcare • 1078 implied HN points • 09 Aug 23
  1. Novo Nordisk released a press release touting study results that were not peer-reviewed or published, raising ethical concerns.
  2. The study population in the trial for the weight loss drug Wegovy was limited to specific criteria, excluding certain groups for evaluation of benefits and risks.
  3. The publicity stunt around the drug's benefits showcases the pharmaceutical company's marketing tactics that may manipulate perceptions and stock prices.
Weight and Healthcare • 1058 implied HN points • 02 Aug 23
  1. Non-compliance labeling in healthcare can have negative implications on patients, especially when it comes to weight loss recommendations.
  2. There is a strong emphasis on the importance of reframing health as supporting behaviors rather than just focusing on weight loss as a measure of compliance.
  3. Many weight loss interventions lack long-term efficacy and can result in weight cycling, leading to patient dissatisfaction and potential harm.